IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA

Summary

The study objective is the eluciation of the dose-response function in efficacy (and possibly safety) in order to determine an optimal dose with respect to efficacy and safety. The study is designed with three dose levels and one placebo control.

Timeline

Start

2005-07

Primary completion

—

Completion

2006-05

Drugs

Indications